Ecuador Medical Device Registration 2026: Local Labeling and Conditioning under Article 58

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Article 58 permits imported devices to undergo conditioning (acondicionamiento) within Ecuador, before commercialization, in order to comply with the registration requirements, subject to three conditions: the conditioning establishment must hold a current good manufacturing practice (BPM) certificate for devices or a current ISO 13485 certificate registered with ARCSA, and must be recorded in the registration certificate as the conditioning party; establishments performing only marking (marcaje) activities may act with a current BPADT certification issued by ARCSA. Neither conditioning nor marking may affect the stability of the product, the integrity of the primary container or its seal.

2. Legal basis

RegulationReference numberPublication dateArticle provisions
Substitute Technical Sanitary Regulation for the Registration, Control and Surveillance of Medical Devices for Human UseResolución ARCSA-DE-2026-003-DASPSigned 2026-04-28Article 58 (domestic conditioning)
Same regulationSameSameArticle 3 (definition of conditioning), Articles 61 to 63 (BPM and ISO 13485 registration)
Same regulationSameSameTransitory general provision six (BPADT), Article 49 (labeling elements)
Parent regulation on good practices for storage, distribution and transportResolución ARCSA-DE-002-2020-LDCL, Registro Oficial Edición Especial 4552020-03-19Full text

Definition of conditioning in Article 3: the entire set of operations of labeling, packaging and marking (etiquetado, empaque y rotulado) performed so that a finished product complies with the regulations in force and can be distributed and commercialized. Conditioning of imported devices may be performed only on the secondary container; where the device has no secondary container, it is performed on the primary container.

3. Expert insights

Insight 1: Articles 3 and 58 together set an operating-level limit for conditioning. The definition makes clear that conditioning of imported devices may be performed only on the secondary container, and on the primary container only where no secondary container exists. This restriction protects the integrity of the original primary packaging, which is the layer that carries the sterile barrier and the manufacturer’s original labeling.

Insight 2: The thresholds for conditioning and for marking differ, creating a two-tier channel. The two tiers differ in both the certificates demanded of the establishment and the registration formalities that attach to the product itself.

  • Conditioning (labeling, packaging, marking): requires a BPM certificate, or an ISO 13485 certificate registered with ARCSA, and the establishment must be recorded in the registration certificate as the conditioning party;
  • Marking only (marcaje): a current BPADT certification issued by ARCSA is sufficient.

The threshold for marking only is clearly lower than that for full conditioning, which is an important cost optimization point for product lines with many SKUs. Where the only change needed for the Ecuadorian market is an additional or replacement label, routing the work through a marking-only establishment avoids the BPM or ISO 13485 requirement and the registration entry of a conditioning party altogether.

Insight 3: The negative conditions of Article 58 are three and they apply cumulatively. Conditioning or marking activities may not affect the stability of the product, the integrity of the primary container, or the seal of the primary container. If any one of the three is affected, the operation is non-compliant.

Insight 4: The conditioning party must be recorded in the registration certificate. Article 58 requires that the establishment figure as the conditioning party in the registration certificate (mismo que debe figurar como acondicionador en el registro sanitario). This means that changing the conditioning establishment requires the change procedure, and Article 42(c) expressly lists a change of the name or business name of the conditioning establishment among the cases that do not require re-registration. The practical consequence is that the choice of conditioning site should not be treated as a pure logistics decision, because once it is written into the certificate, moving it consumes a change cycle with its own review period and single deficiency response window.

Insight 5: Article 59 provides a separate raw material import route for domestic pilot batches. That provision states that for the production of pilot batches (lotes pilotos) of domestic products, ARCSA will issue an import authorization allowing the import of a sufficient quantity of raw materials that have been validated by the manufacturing process. This is of practical value to manufacturers from the Chinese mainland planning to establish local production in Ecuador. It allows the first local production runs to proceed on imported inputs while the domestic manufacturing authorization chain is still being completed, rather than forcing the pilot phase to wait for the full domestic supply chain to exist.

4. Practical recommendations

  1. Assess whether the marking-only route fits the product: where only a label must be applied, a BPADT establishment suffices, without BPM or ISO 13485.
  2. Record the conditioning party in the registration certificate, and update it through the change procedure whenever it moves (Article 42(c)).
  3. Write conditioning operating procedures that define control points ensuring the stability and the primary container seal are not affected, and keep the records available for inspection at the establishment.
  4. Check whether the product has a secondary container, and fix the conditioning operating level accordingly.
  5. Manufacturers establishing local production should use Article 59 to apply for the pilot batch raw material import authorization.

5. Verification checklist

  • □ The choice between conditioning and marking only has been made and the matching route selected
  • □ The conditioning or marking establishment holds the corresponding certificate (BPM, registered ISO 13485 or BPADT)
  • □ The conditioning party is recorded in the registration certificate
  • □ The conditioning procedures include control points for stability and seal integrity
  • □ The conditioning operating level has been confirmed (secondary container first)
  • □ Local manufacturers have assessed the Article 59 pilot batch route

Regulatory information verified as of October 29, 2026

GRZAN service note

GRZAN provides regulatory support in this country for medical device manufacturers, importers and authorized representatives, covering registration pathway planning, local conditioning and labeling strategy design, licensing structure design, official fee and timeline estimation, technical dossier preparation, and post-market compliance management. Manufacturers and importers planning domestic labeling or conditioning operations in Ecuador may contact GRZAN at info@grzanglobal.com for a tailored solution.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail